CD8A and dermatological toxicity: Oral ABC (1% w/w) treatment for 1 week triggered skin toxicity that could be considered AHS in B*57:01-Tg/PD-1−/− mice due to the infiltration of CD8+ T cells into the dermic layer in the ear and the concurrent occurrence of ear redness (Fig. 4a).